CAR-T Cell Therapy
What Are CAR-T Cells?
They originate from T cells, which are a type of white blood cell responsible for identifying and fighting abnormal or infected cells in the body.
In CAR-T therapy, these T cells are collected and engineered to target specific markers found on cancer cells, enabling a more directed and controlled immune response.
How CAR-T Cells Function?
What Are CAR-T Cells?
They originate from T cells, which are a type of white blood cell responsible for identifying and fighting abnormal or infected cells in the body.
In CAR-T therapy, these T cells are collected and engineered to target specific markers found on cancer cells, enabling a more directed and controlled immune response.
How CAR-T Cells Function?
CAR-T Cell Therapy
CAR-T Cell Therapy
CAR-T therapy works by:
Where CAR-T Cell Therapy May Be Considered
(Suitability depends on diagnosis, disease stage, prior treatments, and clinical evaluation.)
B-cell Acute Lymphoblastic Leukemia (ALL)
Lymphoma
Multiple Myeloma
Where CAR-T Cell Therapy May Be Considered
(Suitability depends on diagnosis, disease stage, prior treatments, and clinical evaluation.)
B-cell Acute Lymphoblastic Leukemia (ALL)
Diffuse Large B-Cell Lymphoma (DLBCL)
Primary Mediastinal Large B-Cell Lymphoma (PMBCL)
Type of Stem Cells
Embryonic Stem Cells (ESCs)
Mesenchymal Stem Cells (MSCs)
Induced Pluripotent Stem Cells (iPSCs)
Situations requiring a more targeted immunotherapy approach
Patients undergoing specialist oncology evaluation
Featured Solutions
Who May Consider CAR-T Cell Therapy?
Specific cancer cases where conventional treatments have limited response
Situations requiring a more targeted immunotherapy approach
Patients undergoing specialist oncology evaluation
Featured Solutions
Who May Consider CAR-T Cell Therapy?
Specific cancer cases where conventional treatments have limited response
CAR-T Cell Therapy Process
01
T Cell Collection
02
Genetic Modification
03
Cell Expansion
04
Quality and Safety Assessment
05
Reinfusion (Administration)
06
Monitoring and Follow-Up
CAR-T Cell Therapy Process
01
T Cell Collection
02
Genetic Modification
03
Cell Expansion
04
Quality and Safety Assessment
05
Reinfusion (Administration)
06
Monitoring and Follow-Up
Understanding CAR-T Therapy:
Complexities and Considerations
Due to its complexity, the therapy is conducted in specialized centers with appropriate expertise and facilities, and all decisions should be made in consultation with qualified oncology specialists.
It requires strict eligibility criteria, close clinical monitoring, and administration within regulated medical environments, and is not suitable for all individuals.
Understanding CAR-T Therapy:
Complexities and Considerations
Due to its complexity, the therapy is conducted in specialized centers with appropriate expertise and facilities, and all decisions should be made in consultation with qualified oncology specialists.
It requires strict eligibility criteria, close clinical monitoring, and administration within regulated medical environments, and is not suitable for all individuals.
Stem Cell Rejuvenation
Selected Research & Publications
Find all the tools you’ll need to create advanced websites in one place. Stop waisting time searching for solutions.
We strive to innovate when it comes to functionality. Our mission is to be the best, come and join the ride.
Add more power to Elementor using our creative elements and make your projects look prettier than ever before.
Each and every one of our customers receives personalised assistance from our dedicated support team.
Frequently Asked Questions
Popular Questions
Get Clarity, Feel Confident
CAR-T is primarily indicated for patients with specific blood cancers who have limited options with standard treatments, as determined by an oncology specialist.
The process from T cell collection to reinfusion typically takes several weeks to months, including lab processing and safety checks.
Side effects can include immune reactions, fever, or low blood counts. Close medical monitoring helps manage these safely.
Frequently Asked Questions
Popular Questions
Get Clarity, Feel Confident
CAR-T is primarily indicated for patients with specific blood cancers who have limited options with standard treatments, as determined by an oncology specialist.
The process from T cell collection to reinfusion typically takes several weeks to months, including lab processing and safety checks.
Side effects can include immune reactions, fever, or low blood counts. Close medical monitoring helps manage these safely.
Schedule Your Specialist Evaluation
Meet with our team to review your condition, explore CAR-T therapy options, and plan the next steps safely and confidently.
Schedule Your Specialist Evaluation
Meet with our team to review your condition, explore CAR-T therapy options, and plan the next steps safely and confidently.